Dysregulation of the JAK/STAT3 signaling pathway is a well-established driver of CRC pathogenesis, promoting tumor progression and metastasis through enhanced proliferation, anti-apoptotic effects, and increased invasiveness (Pennel et al., 2024; Wang and Sun, 2014). This evidence concerns the gene STAT3 and neoplasm.